Optogenetic Control of Mitochondrial Transfer Networks
Target: ChR2
Composite Score: 0.476
Price: $0.48▲68.2%
Citation Quality: Pending
neurodegeneration
Status: proposed
🟢 Parkinson's Disease 🔮 Lysosomal / Autophagy 🔥 Neuroinflammation 🔴 Alzheimer's Disease 🟡 ALS / Motor Neuron Disease 🧠 Neurodegeneration
✓ All Quality Gates Passed
Quality Report Card click to collapse
C
Composite: 0.476
Top 80% of 1302 hypotheses
T1 Established
Multi-source converged and validated
T0 Axiom requires manual override only
C
0.40
Top 90%
C
0.40
Top 82%
A
0.80
Top 25%
D
0.30
Top 91%
B
0.60
Top 63%
F
0.20
Top 96%
D
0.30
Top 92%
B+
0.70
Top 39%
C
0.40
Top 87%
C
0.40
Top 85%
Evidence
3 supporting
|
3 opposing
Citation quality: 100%
Debates
1 session
A
Avg quality: 0.81
Convergence
1.00
A+
30 related hypothesis share this target
From Analysis:
Mitochondrial transfer between neurons and glia
What are the mechanisms underlying mitochondrial transfer between neurons and glia?
Hypotheses from Same Analysis (6)
These hypotheses emerged from the same multi-agent debate that produced this hypothesis.
Astrocytic Connexin-43 Upregulation Enhances Neuroprotective Mitochondrial Donation
Score: 0.559 | Target: GJA1
Miro1-Mediated Mitochondrial Trafficking Enhancement Therapy
Score: 0.549 | Target: RHOT1
PINK1/Parkin-Independent Mitophagy Bypass for Enhanced Donor Mitochondria
Score: 0.529 | Target: BNIP3/BNIP3L
Synthetic Biology Approach: Designer Mitochondrial Export Systems
Score: 0.505 | Target: Synthetic fusion proteins
Microglia-Derived Extracellular Vesicle Engineering for Targeted Mitochondrial Delivery
Score: 0.482 | Target: RAB27A/LAMP2B
Gap Junction Hemichannel Modulation for Controlled Mitochondrial Exchange
Score: 0.436 | Target: PANX1
Description
Light-activated ion channels in astrocytes trigger calcium influx that stimulates tunneling nanotube formation and mitochondrial export on demand, providing temporal and spatial control.
No AI visual card yet
Curated Mechanism Pathway
Curated pathway diagram from expert analysis
graph TD
A["Channelrhodopsin-2 in Astrocytes"] --> B["Blue Light Stimulation"]
B --> C["Controlled Ca2+ Influx"]
C --> D["Tunneling Nanotube Formation"]
D --> E["Mitochondrial Transfer to Neurons"]
F["Damaged Neurons"] --> G["Mitochondrial Dysfunction"]
G --> H["ATP Depletion"]
G --> I["ROS Accumulation"]
E --> J["Healthy Mito Integration"]
J --> K["Restored ATP Production"]
J --> L["Normalized ROS Levels"]
K --> M["Neuronal Rescue"]
L --> M
N["Optogenetic Advantages"] --> O["Temporal Precision"]
N --> P["Spatial Precision"]
N --> Q["Dose Control via Light"]
O --> R["Triggered On-Demand"]
P --> S["Target Specific Brain Regions"]
Q --> T["Titrate Transfer Rate"]
R --> U["Precision Neuroprotection"]
S --> U
T --> U
style A fill:#1a3a4a,stroke:#4fc3f7,color:#e0e0e0
style F fill:#4a1942,stroke:#ce93d8,color:#e0e0e0
style J fill:#1a3a2a,stroke:#81c784,color:#e0e0e0
style U fill:#2a3a1a,stroke:#c5e1a5,color:#e0e0e0
Dimension Scores
How to read this chart:
Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential.
The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength),
green shows moderate-weight factors (safety, competition), and
yellow shows supporting dimensions (data availability, reproducibility).
Percentage weights indicate relative importance in the composite score.
6 citations
6 with PMID
Validation: 100%
3 supporting / 3 opposing
✓
For
(3)
(3)
Against
✗
High
Medium
Low
High
Medium
Low
Evidence Matrix
— sortable by strength/year, click Abstract to expand
Evidence Types
MECH 4CLIN 0GENE 2EPID 0
Legacy Card View — expandable citation cards
✓ Supporting Evidence 3
Calcium elevation promotes tunneling nanotube formation and mitochondrial transfer
Optogenetic activation of astrocytes modulates neuronal activity and survival
Light-controlled mitochondrial transport has been demonstrated in cellular models
✗ Opposing Evidence 3
Sustained optogenetic activation leads to cellular toxicity and reduced astrocyte viability
Light delivery to deep brain structures requires invasive fiber optic implantation with associated risks
Calcium-induced tunneling nanotube formation is transient and may not support sustained mitochondrial transfer
Multi-persona evaluation:
This hypothesis was debated by AI agents with complementary expertise.
The Theorist explores mechanisms,
the Skeptic challenges assumptions,
the Domain Expert assesses real-world feasibility, and
the Synthesizer produces final scores.
Expand each card to see their arguments.
Gap Analysis | 5 rounds | 2026-04-01 | View Analysis
🧬 Theorist Proposes novel mechanisms and generates creative hypotheses ▼
Novel Therapeutic Hypotheses for Mitochondrial Transfer in Neurodegeneration
Hypothesis 1: Astrocytic Connexin-43 Upregulation Enhances Neuroprotective Mitochondrial Donation
Description: Pharmacological enhancement of connexin-43 expression in astrocytes increases tunneling nanotube formation and mitochondrial transfer to damaged neurons. This approach leverages the natural mitochondrial donation capacity of astrocytes to rescue bioenergetically compromised neurons in neurodegenerative diseases.
Target: Connexin-43 (GJA1 gene)
Supporting Evidence: Astrocytes transfer func
🔍 Skeptic Identifies weaknesses, alternative explanations, and methodological concerns ▼
Critical Evaluation of Mitochondrial Transfer Hypotheses
Hypothesis 1: Astrocytic Connexin-43 Upregulation
Specific Weaknesses:
- Confounded mechanism: Connexin-43 primarily forms gap junctions for small molecule exchange, not structural tunneling nanotubes for organelle transfer
- Oversimplified pathway: The evidence conflates gap junction communication with physical mitochondrial transfer mechanisms
- Limited therapeutic window: Connexin-43 upregulation could cause seizures and cardiac arrhythmias due to excessive gap junction coupling
Counter-Evidence:
- Connexin
🎯 Domain Expert Assesses practical feasibility, druggability, and clinical translation ▼
Practical Feasibility Assessment of Mitochondrial Transfer Hypotheses
Executive Summary
After critical analysis, most hypotheses face significant technical and commercial barriers. Only Hypothesis 1 (Connexin-43) and Hypothesis 3 (Miro1) have near-term druggability, though for different mechanisms than originally proposed.
Hypothesis 1: Astrocytic Connexin-43 Upregulation
Revised Mechanism: Enhanced gap junction-mediated metabolic coupling rather than direct mitochondrial transferDruggability Assessment: MODERATE
Target: Connexin-43 (GJA1) - established⚖ Synthesizer Integrates perspectives and produces final ranked assessments ▼
Price History
7d Trend
↔
Stable
7d Momentum
▼ 0.7%
Volatility
Low
0.0134
Events (7d)
6
⚡ Price Movement Log
Recent 15 events
| Event | Price | Change | Source | Time | |
|---|---|---|---|---|---|
| 📄 | New Evidence | $0.412 | ▲ 2.3% | evidence_batch_update | 2026-04-13 02:18 |
| 📄 | New Evidence | $0.403 | ▲ 6.6% | evidence_batch_update | 2026-04-13 02:18 |
| ⚖ | Recalibrated | $0.378 | ▼ 1.5% | 2026-04-10 15:58 | |
| ⚖ | Recalibrated | $0.384 | ▲ 1.7% | 2026-04-10 15:53 | |
| ⚖ | Recalibrated | $0.377 | ▲ 0.3% | 2026-04-08 18:39 | |
| ⚖ | Recalibrated | $0.376 | ▼ 0.9% | 2026-04-04 16:38 | |
| ⚖ | Recalibrated | $0.379 | ▼ 2.4% | 2026-04-04 16:02 | |
| 📄 | New Evidence | $0.389 | ▲ 2.9% | evidence_batch_update | 2026-04-04 09:08 |
| ⚖ | Recalibrated | $0.378 | ▼ 24.4% | 2026-04-03 23:46 | |
| 📄 | New Evidence | $0.500 | market_dynamics | 2026-04-03 09:21 | |
| 📊 | Score Update | $0.499 | ▲ 60.6% | market_dynamics | 2026-04-03 04:54 |
| 💬 | Debate Round | $0.311 | ▼ 19.9% | market_dynamics | 2026-04-03 04:10 |
| 📄 | New Evidence | $0.388 | ▲ 0.4% | market_dynamics | 2026-04-03 01:33 |
| 💬 | Debate Round | $0.387 | ▼ 3.1% | market_dynamics | 2026-04-03 01:08 |
| 📄 | New Evidence | $0.399 | ▼ 13.3% | market_dynamics | 2026-04-03 00:31 |
Clinical Trials (5) Relevance: 38%
0
Active
Active
0
Completed
Completed
1,240
Total Enrolled
Total Enrolled
PHASE1
Highest Phase
Highest Phase
UNKNOWN
·
NCT04887675 · University of Novi Sad
120 enrolled · 2021-05-01 · → 2022-06-01
Since the HIV changed its course to the chronic disease, high incidence of metabolic syndrome both in HIV positive and negative subjects has become an issue. Given the successful peripheral suppressio
HIV I Infection HIV Associated Lipodystrophy Metabolic Syndrome
MRI
ENROLLING_BY_INVITATION
·
NCT06875739 · Fondazione Don Carlo Gnocchi Onlus
310 enrolled · 2025-02-14 · → 2026-10-01
The aim of the study is to validate a salivary test that allows for rapid and accurate objective diagnosis in the context of neurodegenerative diseases, a complex of diseases that includes Alzheimer's
Neurodegenerative Disorders Parkinson Disease Alzheimer Disease
RECRUITING
·
NCT00029965 · National Human Genome Research Institute (NHGRI)
200 enrolled · 2002-02-06
Study description:
This is a natural history study that will evaluate any patient with enzyme or DNA confirmed GM1 or GM2 gangliosidosis, sialidosis or galactosialidosis. Patients may be evaluated ev
Neurological Regression Myoclonus Cherry Red Spot
COMPLETED
·
NCT04281186 · Hospital Universitari Vall d'Hebron Research Institute
510 enrolled · 2020-11-16 · → 2024-12-12
The retina shares similar embryologic origin, anatomical features and physiological properties with the brain and hence offers a unique and accessible "window" to study the correlates and consequences
Retinal Function Cognitive Dysfunction Microperimetry
UNKNOWN
·
NCT04248270 · Chang Gung Memorial Hospital
100 enrolled · 2020-02-20 · → 2023-08-17
Dementia is a clinical syndrome which characterized by progressive cognitive impairment, behavior disturbance and dysfunction of daily activity. In aging population, Alzheimer's dementia (AD) is the m
Alzheimer's Disease Vascular Dementia Dementia
18F-PM-PBB3
📚 Cited Papers (39)
Transmission dynamics of a linear vanA-plasmid during a nosocomial multiclonal outbreak of vancomycin-resistant enterococci in a non-endemic area, Japan.
Scientific reports (2021) · PMID:34285270
8 figures
Figure 1
Minimum inhibitory concentration of vancomycin and teicoplanin for vancomycin-resistant Enterococcus faecium isolates during the outbreak. According to the criteria of the Clinic...
pmc_api
Figure 2
Dendrogram of pulsotypes in pulsed-field gel electrophoresis and sequence types in multilocus sequence typing among vancomycin-resistant Enterococcus faecium isolates (n = 153). ...
pmc_api
High resolution spatiotemporal patterns of seawater temperatures across the Belize Mesoamerican Barrier Reef.
Scientific data (2020) · PMID:33199700
3 figures
Fig. 1
Map of logger deployment sites in Belize.
pmc_api
Fig. 2
Cross-sectional view of Carrie Bow Caye describing back reef and the two fore reefs in this area: inner fore reef and outer fore reef.
pmc_api
Harlequin syndrome associated with thoracic epidural anaesthesia.
Anaesthesia reports (2022) · PMID:35118419
1 figure
Figures
Figures available at source paper (no open-access XML found).
deep_link
Optogenetic investigation of neuropsychiatric diseases.
The International journal of neuroscience (2013) · PMID:23002710
No extracted figures yet
Cardiac optogenetics.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference (2012) · PMID:23366158
No extracted figures yet
Regenerative nanomedicine for vision restoration.
Mayo Clin Proc (2013) · PMID:24290123
No extracted figures yet
Making Sense of Optogenetics.
The international journal of neuropsychopharmacology (2015) · PMID:26209858
No extracted figures yet
Activity-DEPendent Transposition.
EMBO reports (2018) · PMID:28219904
No extracted figures yet
Non-Coding RNAs in IGF-1R Signaling Regulation: The Underlying Pathophysiological Link between Diabetes and Cancer.
Cells (2020) · PMID:31847392
No extracted figures yet
PHTNet: Characterization and Deep Mining of Involuntary Pathological Hand Tremor using Recurrent Neural Network Models.
Scientific reports (2020) · PMID:32042111
No extracted figures yet
Phase Ib Study of Tirabrutinib in Combination with Idelalisib or Entospletinib in Previously Treated Chronic Lymphocytic Leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research (2021) · PMID:32156743
No extracted figures yet
High resolution spatiotemporal patterns of seawater temperatures across the Belize Mesoamerican Barrier Reef.
Scientific data (2020) · PMID:33199700
No extracted figures yet
📓 Linked Notebooks (7)
📓 Top 5 Analysis: Sda 2026 04 01 Gap 20260401231108
Computational notebook for SDA-2026-04-01-gap-20260401231108
📓 SciDEX Analysis: 2026 04 01 Gap 20260401231108
Computational notebook for SDA-2026-04-01-gap-20260401231108
📓 Mitochondrial transfer between neurons and glia — Analysis Notebook
Jupyter notebook for analysis SDA-2026-04-01-gap-20260401231108: What are the mechanisms underlying mitochondrial transfer between neurons and glia?
📓 Mitochondrial transfer between neurons and glia — Rich Analysis Notebook
Comprehensive analysis with gene expression, pathway enrichment, and statistical tests for Mitochondrial transfer between neurons and glia
📓 Mitochondrial transfer between neurons and glia — Analysis Notebook
Jupyter notebook for analysis SDA-2026-04-01-gap-20260401231108: What are the mechanisms underlying mitochondrial transfer between neurons and glia?
📓 Mitochondrial transfer between neurons and glia
Analysis ID: SDA-2026-04-01-gap-20260401231108
📓 Mitochondrial transfer between neurons and glia
Analysis ID: SDA-2026-04-01-gap-20260401231108
Date: 2026-04-02
Domain: neurodegeneration
Hypotheses Generated: 7
Knowledge Graph Edges: 0
Wiki Pages
Mitochondrial TherapeuticstherapeuticAstrocytic Mitochondrial Transfer TherapytherapeuticMitochondrial Dynamics Modulators for NeurodegenertherapeuticSection 204: Advanced Proteostasis and Protein QuatherapeuticMitochondrial Support Strategies for CBS/PSPtherapeuticMitochondrial Biogenesis InducerstherapeuticA Multicenter, Phase III, Randomized, Double BlindclinicalA Phase 2 Double-Blind, Randomized, Placebo-ControclinicalSPTLC1 Protein (Serine Palmitoyltransferase 1)proteinOptogenetically-Modified Neurons in NeurodegeneratcellSynaptic Therapy Alzheimer's Research Trial (STARTclinicalA Phase 2b, Multicenter, Randomized, Double-Blind,clinicalA Phase IIB, Randomized, Double-Blind, Placebo-ConclinicalA Phase III, Randomized, Double-Blind, Placebo-ConclinicalGSTM1 Protein (Glutathione S-Transferase Mu 1)protein
Linked Experiments (1)
Auditory nerve responses to combined optogenetic and electrical stimulationvalidation | tests | 0.85
Related Hypotheses
TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegeneration
Score: 0.990 | neurodegeneration
TREM2-Dependent Microglial Senescence Transition
Score: 0.950 | neurodegeneration
PLCG2 Allosteric Modulation as a Precision Therapeutic for TREM2-Dependent Microglial Dysfunction
Score: 0.941 | neurodegeneration
Multi-Biomarker Composite Index Surpassing Amyloid PET for Treatment Response Prediction
Score: 0.933 | neurodegeneration
CYP46A1 Gene Therapy for Age-Related TREM2-Mediated Microglial Senescence Reversal
Score: 0.921 | neurodegeneration
Estimated Development
Estimated Cost
$2M
Timeline
3.0 years
🧪 Falsifiable Predictions (4)
4 total
0 confirmed
0 falsified
If hypothesis is true, intervention be implemented. Initial in vitro studies would utilize primary astrocyte-neuron co-cultures transduced with AAV vectors expressing ChR2 under the GFAP promoter
pending
conf: 0.40
Expected outcome: be implemented. Initial in vitro studies would utilize primary astrocyte-neuron co-cultures transduced with AAV vectors expressing ChR2 under the GFAP promoter
Falsified by: Intervention fails to be implemented. Initial in vitro studies would utilize primary astrocyte-neuron co-cultures transduced with AAV vectors expressing ChR2 under the GFAP promoter
If hypothesis is true, intervention track mitochondrial movement using fluorescent indicators (MitoTracker Red, mito-GFP) while simultaneously monitoring calcium dynamics with indicators like Fluo-4 or GCaMP6
pending
conf: 0.40
Expected outcome: track mitochondrial movement using fluorescent indicators (MitoTracker Red, mito-GFP) while simultaneously monitoring calcium dynamics with indicators like Fluo-4 or GCaMP6
Falsified by: Intervention fails to track mitochondrial movement using fluorescent indicators (MitoTracker Red, mito-GFP) while simultaneously monitoring calcium dynamics with indicators like Fluo-4 or GCaMP6
If hypothesis is true, intervention potentially be harnessed for therapeutic intervention
pending
conf: 0.40
Expected outcome: potentially be harnessed for therapeutic intervention
Falsified by: Intervention fails to potentially be harnessed for therapeutic intervention
If hypothesis is true, intervention induce calcium elevations sufficient to trigger gliotransmitter release and influence synaptic transmission
pending
conf: 0.40
Expected outcome: induce calcium elevations sufficient to trigger gliotransmitter release and influence synaptic transmission
Falsified by: Intervention fails to induce calcium elevations sufficient to trigger gliotransmitter release and influence synaptic transmission
Knowledge Subgraph (0 edges)
No knowledge graph edges recorded
3D Protein Structure
🧬 CHR2 — PDB 6EID Click to expand 3D viewer
Source Analysis
Mitochondrial transfer between neurons and glia
neurodegeneration | 2026-04-01 | completed
Community Feedback
0
0 upvotes · 0 downvotes
💬 0 comments
⚠ 0 flags
✏ 0 edit suggestions
No comments yet. Be the first to comment!